Fabentech raises €8.5M Series A round
20 January 2020· Lyon, France· health, biotech, materials, b2b, b2g, deep_hardware
To accelerate the development and marketing of its passive immunotherapy treatments and to develop and produce treatments which will open the door to new niche markets.
Investors
LeadDefinvest
Also participating
BpifranceInstitut MérieuxElaiaSigma GestionKreaxiBertrand Lépine
About Fabentech
Stage
Series A
Headquarters
Lyon, France
Founded
2009
Team Size
21–50
Sectors
healthbiotechmaterialsb2bb2gdeep_hardware